Homers regulate drug-induced neuroplasticity: Implications for addiction

Biochemical Pharmacology

Volumn 75, Issue 1, 2008, Pages 112-133

  Szumlinski, Karen K ^a   Ary, Alexis W ^a   Lominac, Kevin D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Addiction; Glutamate; Homer proteins; Nucleus accumbens; Prefronal cortex; Prenatal stress

Indexed keywords

COCAINE; CYCLOHEXIMIDE; GLUTAMATE RECEPTOR; LYSERGIDE; METHAMPHETAMINE; MORPHINE; NALOXONE; NICOTINE; PENTETRAZOLE; PHENCYCLIDINE; PROTEIN HOMER 1; PROTEIN HOMER 1A; PROTEIN HOMER 1B; PROTEIN HOMER 1C; PROTEIN HOMER 3;

ALCOHOL ABUSE; ARTICLE; BRAIN CORTEX; BRAIN REGION; DRUG ABUSE; DRUG DEPENDENCE; GENETIC PREDISPOSITION; NERVE CELL PLASTICITY; NEUROCHEMISTRY; NEUROTRANSMISSION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; UNTRANSLATED REGION;

ANIMALS; CARRIER PROTEINS; COCAINE; ETHANOL; GLUTAMIC ACID; HUMANS; METHAMPHETAMINE; NEURONAL PLASTICITY; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; SCHIZOPHRENIA; SUBSTANCE-RELATED DISORDERS;

EID: 36849090854     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2007.07.031     Document Type: Article

References (335)

1. Bickel WK, Miller ML, Yi R, Kowal BP, Lindquist DM, Pitcock JA. Behavioral and neuroeconomics of drug addiction: Competing neural systems and temporal discounting processes. Drug Alcohol Depend; in press.
2. Everitt B.J., and Wolf M.E. Psychomotor stimulant addiction: a neural systems perspective. J Neurosci 22 (2002) 3312-3320
3. Hyman S.E., Malenka R.C., and Nestler E.J. Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci 29 (2006) 565-598
4. Kalivas P.W., Volkow N., and Seamans J. Unmanageable motivation in addiction: a pathology in prefrontal-accumbens glutamate transmission. Neuron 45 (2005) 647-650
5. Dom G., Sabbe B., Hulstijn W., and van den Brink W. Substance use disorders and the orbitofrontal cortex: systematic review of behavioural decision-making and neuroimaging studies. Br J Psychiatry 187 (2005) 209-220
6. Garavan H., Pankiewicz J., Bloom A., Cho J.K., Sperry L., Ross T.J., et al. Cue-induced cocaine craving: neuroanatomical specificity for drug users and drug stimuli. Am J Psychiatry 157 (2000) 1789-1798
7. Goldstein R.Z., and Volkow N.D. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 159 (2002) 1642-1652
8. Wexler B.E., Gottschalk C.H., Fulbright R.K., Prohovnik I., Lacadie C.M., Rounsaville B.J., et al. Functional magnetic resonance imaging of cocaine craving. Am J Psychiatry 158 (2001) 86-95
9. Xiao Z., Lee T., Zhang J.X., Wu Q., Wu R., Weng X., et al. Thirsty heroin addicts show different fMRI activations when exposed to water-related and drug-related cues. Drug Alcohol Depend 83 (2006) 157-162
10. Bolla K.I., Eldreth D.A., Matochik J.A., and Cadet J.L. Neural substrates of faulty decision-making in abstinent marijuana users. Neuroimage 26 (2005) 480-492
11. Cochran S.M., Kennedy M., McKerchar C.E., Steward L.J., Pratt J.A., and Morris B.J. Induction of metabolic hypofunction and neurochemical deficits after chronic intermittent exposure to phencyclidine: differential modulation by antipsychotic drugs. Neuropsychopharmacology 28 (2003) 265-275
12. Crockford D.N., Goodyear B., Edwards J., Quickfall J., and el-Guebaly N. Cue-induced brain activity in pathological gamblers. Biol Psychiatry 58 (2005) 787-795
13. Goldstein R.Z., Volkow N.D., Chang L., Wang G.J., Fowler J.S., Depue R.A., et al. The orbitofrontal cortex in methamphetamine addiction: involvement in fear. Neuroreport 13 (2002) 2253-2257
14. Lingford-Hughes A.R., Daglish M.R., Stevenson B.J., Feeney A., Pandit S.A., Wilson S.J., et al. Imaging alcohol cue exposure in alcohol dependence using a PET 15O-H2O paradigm: results from a pilot study. Addict Biol 11 (2006) 107-115
15. Grusser S.M., Wrase J., Klein S., Hermann D., Smolka M.N., Ruf M., et al. Cue-induced activation of the striatum and medial prefrontal cortex is associated with subsequent relapse in abstinent alcoholics. Psychopharmacology 175 (2004) 296-302
16. Okuyemi K.S., Powell J.N., Savage C.R., Hall S.B., Nollen N., Holsen L.M., et al. Enhanced cue-elicited brain activation in African American compared with Caucasian smokers: an fMRI study. Addict Biol 11 (2006) 97-106
17. Tanabe J, Crowley T, Hutchison K, Miller D, Johnson G, Du YP, et al. Ventral striatal blood flow is altered by acute nicotine but not withdrawal from nicotine. Neuropsychopharmacology; in press, doi:10.1038/sj.npp.1301428.
18. Steketee J.D. Cortical mechanisms of cocaine sensitization. Crit Rev Neurobiol 17 (2005) 69-86
19. Vanderschuren L.J., and Kalivas P.W. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology 151 (2000) 99-120
20. Wolf M.E. The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog Neurobiol 54 (1998) 679-720
21. Robinson T.E., and Berridge K.C. Incentive-sensitization and addiction. Addiction 96 (2001) 103-114
22. Kalivas P.W., and Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Brain Res Rev 16 (1991) 223-244
23. Kalivas P.W., and McFarland K. Brain circuitry and the reinstatement of cocaine-seeking behavior. Psychopharmacology 168 (2003) 44-56
24. Schmidt H.D., Anderson S.M., Famous K.R., Kumaresan V., and Pierce R.C. Anatomy and pharmacology of cocaine priming-induced reinstatement of drug seeking. Eur J Pharmacol 526 (2005) 65-76
25. Sun W., Akins C.K., Mattingly A.E., and Rebec G.V. Ionotropic glutamate receptors in the ventral tegmental area regulate cocaine-seeking behavior in rats. Neuropsychopharmacology 30 (2005) 2073-2081
26. Stewart J. Stress and relapse to drug seeking: studies in laboratory animals shed light on mechanisms and sources of long-term vulnerability. Am J Addict 12 (2003) 1-17
27. Vezina P. Sensitization of midbrain dopamine neuron reactivity and the self-administration of psychomotor stimulant drugs. Neurosci Biobehav Rev 27 (2004) 827-839
28. Bowers M.S., McFarland K., Lake R.W., Peterson Y.K., Lapish C.C., Gregory M.L., et al. Activator of G protein signaling 3: a gatekeeper of cocaine sensitization and drug seeking. Neuron 42 (2004) 269-281
29. Kozell L.B., and Meshul C.K. Nerve terminal glutamate immunoreactivity in the rat nucleus accumbens and ventral tegmental area after a short withdrawal from cocaine. Synapse 51 (2004) 224-232
30. Li Y., Hu X.T., Berney T.G., Vartanian A.J., Stine C.D., Wolf M.E., et al. Both glutamate receptor antagonists and prefrontal cortex lesions prevent induction of cocaine sensitization and associated neuroadaptations. Synapse 34 (1999) 169-180
31. Pierce R.C., Bell K., Duffy P., and Kalivas P.W. Repeated cocaine augments excitatory amino acid transmission in the nucleus accumbens only in rats having developed behavioral sensitization. J Neurosci 16 (1996) 1550-1560
32. Pierce R.C., Reeder D.C., Hicks J., Morgan Z.R., and Kalivas P.W. Ibotenic acid lesions of the dorsal prefrontal cortex disrupt the expression of behavioral sensitization to cocaine. Neuroscience 82 (1998) 1103-1114
33. Prasad B.M., Hochstatter T., and Sorg B.A. Expression of cocaine sensitization: regulation by the medial prefrontal cortex. Neuroscience 88 (1999) 765-774
34. Szumlinski K.K., Dehoff M.H., Kang S.H., Frys K.A., Lominac K.D., Klugmann M., et al. Homer proteins regulate sensitivity to cocaine. Neuron 43 (2004) 401-413
35. Szumlinski K.K., Abernathy K.E., Oleson E.B., Klugmann M., Lominac K.D., He D.Y., et al. Homer isoforms differentially regulate cocaine-induced neuroplasticity. Neuropsychopharmacology 31 (2006) 768-777
36. Tzschentke T.M., and Schmidt W.J. Functional heterogeneity of the rat medial prefrontal cortex: effects of discrete subarea-specific lesions on drug-induced conditioned place preference and behavioural sensitization. Eur J Neurosci 11 (1999) 4099-4109
37. Williams J.M., and Steketee J.D. Cocaine increases medial prefrontal cortical glutamate overflow in cocaine-sensitized rats: a time course study. Eur J Neurosci 20 (2004) 1639-1646
38. Szumlinski K.K., Lominac K.D., Oleson E.B., Walker J.K., Mason A., Dehoff M.H., et al. Homer2 is necessary for EtOH-induced neuroplasticity. J Neurosci 25 (2005) 7054-7061
39. Szumlinski KK, Ary AW, Lominac KD, Kippin TE. Facilitation of alcohol-induced neuroplasticity by accumbens Homer2 over-expression. Neuropsychopharmacology; in press, doi:10.1038/sj.npp.1301473.
40. Ma Y.Y., Chu N.N., Guo C.Y., Han J.S., and Cui C.L. NR2B-containing NMDA receptor is required for morphine-but not stress-induced reinstatement. Exp Neurol 203 (2007) 309-319
41. Tzschentke T.M., and Schmidt W.J. Discrete quinolinic acid lesions of the rat prelimbic medial prefrontal cortex affect cocaine- and MK-801-, but not morphine- and amphetamine-induced reward and psychomotor activation as measured with the place preference conditioning paradigm. Behav Brain Res 97 (1998) 115-127
42. Zavala A.R., Weber S.M., Rice H.J., Alleweireldt A.T., and Neisewander J.L. Role of the prelimbic subregion of the medial prefrontal cortex in acquisition, extinction, and reinstatement of cocaine-conditioned place preference. Brain Res 990 (2003) 157-164
43. Boyce-Rustay J.M., and Cunningham C.L. The role of NMDA receptor binding sites in ethanol place conditioning. Behav Neurosci 118 (2004) 822-834
44. Rassnick S., Pulvirenti L., and Koob G.F. Oral ethanol self-administration in rats is reduced by the administration of dopamine and glutamate receptor antagonists into the nucleus accumbens. Psychopharmacology 109 (1992) 92-98
45. Spanagel R., and Heilig M. Addiction and its brain science. Addiction 100 (2005) 1813-1822
46. Sudakov S.K., Rusakova I.V., Trigub M.M., Shakhmatov V.Y., Kozel' A.I., and Smith J.E. Changed morphine sensitivity of morphine-dependent rats after laser exposure of the cerebral prefrontal cortex. Bull Exp Biol Med 141 (2006) 226-229
47. Baker D.A., McFarland K., Lake R.W., Shen H., Tang X.C., Toda S., et al. Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse. Nat Neurosci 6 (2003) 743-749
48. Cornish J.L., and Kalivas P.W. Cocaine sensitization and craving: differing roles for dopamine and glutamate in the nucleus accumbens. J Addict Dis 20 (2001) 43-54
49. Cornish J.L., Duffy P., and Kalivas P.W. A role for nucleus accumbens glutamate transmission in the relapse to cocaine-seeking behavior. Neuroscience 93 (1999) 1359-1367
50. Di Ciano P., and Everitt B.J. Dissociable effects of antagonism of NMDA and AMPA/KA receptors in the nucleus accumbens core and shell on cocaine-seeking behavior. Neuropsychopharmacology 25 (2001) 341-360
51. Di Pietro N.C., Black Y.D., and Kantak K.M. Context-dependent prefrontal cortex regulation of cocaine self-administration and reinstatement behaviors in rats. Eur J Neurosci 24 (2006) 3285-3298
52. McFarland K., Lapish C.C., and Kalivas P.W. Prefrontal glutamate release into the core of the nucleus accumbens mediates cocaine-induced reinstatement of drug-seeking behavior. J Neurosci 23 (2003) 3531-3537
53. McFarland K., Davidge S.B., Lapish C.C., and Kalivas P.W. Limbic and motor circuitry underlying footshock-induced reinstatement of cocaine-seeking behavior. J Neurosci 24 (2004) 1551-1560
54. Backstrom P., and Hyytia P. Suppression of alcohol self-administration and cue-induced reinstatement of alcohol seeking by the mGlu2/3 receptor agonist LY379268 and the mGlu8 receptor agonist (S)-3,4-DCPG. Eur J Pharmacol 528 (2005) 110-118
55. Backstrom P., and Hyytia P. Ionotropic glutamate receptor antagonists modulate cue-induced reinstatement of ethanol-seeking behavior. Alcohol Clin Exp Res 28 (2004) 558-565
56. Backstrom P., Bachteler D., Koch S., Hyytia P., and Spanagel R. mGluR5 antagonist MPEP reduces ethanol-seeking and relapse behavior. Neuropsychopharmacology 29 (2004) 921-928
57. Szumlinski K.K., Frys K.A., and Kalivas P.W. Dissociable roles for the dorsal and median raphe in the facilitatory effect of 5-HT1A receptor stimulation upon cocaine-induced locomotion and sensitization. Neuropsychopharmacology 29 (2004) 1675-1687
58. Reid M.S., and Berger S.P. Evidence for sensitization of cocaine-induced nucleus accumbens glutamate release. NeuroReport 7 (1996) 1325-1329
59. Ito K., Abekawa T., and Koyama T. Relationship between development of cross-sensitization to MK-801 and delayed increases in glutamate levels in the nucleus accumbens induced by a high dose of methamphetamine. Psychopharmacology 187 (2006) 293-302
60. Nash J.F., and Yamamoto B.K. Effect of d-amphetamine on the extracellular concentrations of glutamate and dopamine in iprindole-treated rats. Brain Res 627 (1993) 1-8
61. Xue C.J., Ng J.P., Li Y., and Wolf M.E. Acute and repeated systemic amphetamine administration: effects on extracellular glutamate, aspartate and serine levels in rat ventral tegmental area and nucleus accumbens. J Neurochem 67 (1996) 352-363
62. Reid M.S., Hsu K., and Berger S.P. Cocaine and amphetamine preferentially stimulate glutamate release in the limbic system: studies on the involvement of dopamine. Synapse 27 (1997) 95-105
63. Kalivas P.W., and Duffy P. Dopamine regulation of extracellular glutamate in the nucleus accumbens. Brain Res 761 (1997) 173-177
64. Moghaddam B., and Bolinao M.L. Biphasic effect of ethanol on extracellular accumulation of glutamate in the hippocampus and the nucleus accumbens. Neurosci Lett 178 (1994) 99-102
65. Saellstroem Baum S., Huebner A., Krimphove M., Morgenstern R., Badawy A.A., and Spies C.D. Nicotine stimulation on extracellular glutamate levels in the nucleus accumbens of ethanol-withdrawn rats in vivo. Alcohol Clin Exp Res 30 (2006) 1414-1421
66. Lallemand F., Ward R.J., Dravolina O., and De Witte P. Nicotine-induced changes of glutamate and arginine in naive and chronically alcoholized rats: an in vivo microdialysis study. Brain Res 1111 (2006) 48-60
67. Liu Q., Li Z., Ding J.H., Liu S.Y., Wu J., and Hu G. Iptakalim inhibits nicotine-induced enhancement of extracellular dopamine and glutamate levels in the nucleus accumbens of rats. Brain Res 1085 (2006) 138-143
68. Kashkin V.A., and De Witte P. Nicotine increases microdialysate brain amino acid concentrations and induces conditioned place preference. Eur Neuropsychopharmacol 15 (2005) 625-632
69. Hao Y., Yang J.Y., Guo M., Wu C.F., and Wu M.F. Morphine decreases extracellular levels of glutamate in the anterior cingulate cortex: an in vivo microdialysis study in freely moving rats. Brain Res 1040 (2005) 191-196
70. Jacobs E.H., Wardeh G., Smit A.B., and Schoffelmeer A.N. Morphine causes a delayed increase in glutamate receptor functioning in the nucleus accumbens core. Eur J Pharmacol 511 (2005) 27-30
71. Harris B.R., Prendergast M.A., Gibson D.A., Rogers D.T., Blanchard J.A., Holley R.C., et al. Acamprosate inhibits the binding and neurotoxic effects of trans-ACPD, suggesting a novel site of action at metabotropic glutamate receptors. Alcohol Clin Exp Res 26 (2002) 1779-1793
72. Littleton J. Acamprosate in alcohol dependence: how does it work?. Addiction 90 (1995) 1179-1188
73. Boothby L.A., and Doering P.L. Acamprosate for the treatment of alcohol dependence. Clin Ther 27 (2005) 695-714
74. Mason B.J. Acamprosate in the treatment of alcohol dependence. Expert Opin Pharmacother 6 (2005) 2103-2115
75. Basu D., Jhirwal O.P., and Mattoo S.K. Clinical characterization of use of acamprosate and naltrexone: data from an addiction center in India. Am J Addict 14 (2005) 381-395
76. Rawson R.A., McCann M.J., Hasson A.J., and Ling W. Addiction pharmacotherapy 2000: new options, new challenges. J Psychoact Drugs 32 (2000) 371-378
77. Park W.K., Bari A.A., Jey A.R., Anderson S.M., Spealman R.D., Rowlett J.K., et al. Cocaine administered into the medial prefrontal cortex reinstates cocaine-seeking behavior by increasing AMPA receptor-mediated glutamate transmission in the nucleus accumbens. J Neurosci 22 (2002) 2916-2925
78. Backstrom P., and Hyytia P. Involvement of AMPA/kainate, NMDA, and mGlu5 receptors in the nucleus accumbens core in cue-induced reinstatement of cocaine seeking in rats. Psychopharmacology 192 (2007) 571-580
79. Pulvirenti L., Maldonado-Lopez R., and Koob G.F. NMDA receptors in the nucleus accumbens modulate intravenous cocaine but not heroin self-administration in the rat. Brain Res 594 (1992) 327-330
80. Rodriguez-Borrero E., Bernardo Colon A., Burgos-Martir M.A., Alvarez Carillo J.E., del Campo Y.E., Abella-Ramirez C., et al. NMDA antagonist AP-5 increase environmentally induced cocaine-conditioned locomotion within the nucleus accumbens. Pharmacol Biochem Behav 85 (2006) 178-184
81. Cozzoli D, Goulding S. Szumlinski KK, Accumbens mGluR5 blockade reduces excessive alcohol consumption in mice. Alcohol Clin Exp Res 31 Suppl: 17A.
82. Stromberg M.F., Volpicelli J.R., O'Brien C.P., and Mackler S.A. The NMDA receptor partial agonist, 1-aminocyclopropanecarboxylic acid (ACPC), reduces ethanol consumption in the rat. Pharmacol Biochem Behav 64 (1999) 585-590
83. Cador M., Bjijou Y., Cailhol S., and Stinus L. d-Amphetamine-induced behavioral sensitization: implication of a glutamatergic medial prefrontal cortex-ventral tegmental area innervation. Neuroscience 94 (1999) 705-721
84. Jolly D.C., Kim J.H., and Vezina P. Activation of metabotropic glutamate receptors in the rat ventral tegmental area is necessary for induction of behavioral sensitization to amphetamine. Soc Neurosci Abstr 23 (1997) 1091
85. Attarian S., and Amalric M. Microinfusion of the metabotropic glutamate receptor agonist 1S, 3R-1-aminocyclopentane-1,3-dicarboxylic acid into the nucleus accumbens induces dopamine-dependent locomotor activation in the rat. Eur J Neurosci 9 (1997) 809-816
86. Kim J.H., and Vezina P. Metabotropic glutamate receptors in the rat nucleus accumbens contribute to amphetamine-induced locomotion. J Pharmacol Exp Ther 284 (1998) 317-322
87. Pulvirenti L., Swerdlow N.R., and Koob G.F. Microinjection of a glutamate antagonist into the nucleus accumbens reduces psychostimulant locomotion in rats. Neurosci Lett 103 (1989) 213-218
88. Willins D.L., Wallace L.J., Miller D.D., and Uretsky N.J. α-Amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonists in the nucleus accumbens and ventral pallidum decrease the hypermotility response to psychostimulant drugs. J. Pharmacol Exp Ther. 260 (1992) 1145-1151
89. Karler R., Bedingfield J.B., Thai D.K., and Calder L.D. The role of the frontal cortex in the mouse in behavioral sensitization to amphetamine. Brain Res 757 (1997) 228-235
90. Popik P., and Kolasiewicz W. Mesolimbic NMDA receptors are implicated in the expression of conditioned morphine reward. Naunyn Schmiedebergs Arch Pharmacol 359 (1999) 288-294
91. Pulvirenti L., Swerdlow N.R., and Koob G.F. Nucleus accumbens NMDA antagonist decreases locomotor activity produced by cocaine, heroin or accumbens dopamine, but not caffeine. Pharmacol Biochem Behav 40 (1991) 841-845
92. Liechti M.E., and Markou A. Interactive effects of the mGlu5 receptor antagonist MPEP and the mGlu2/3 receptor antagonist LY341495 on nicotine self-administration and reward deficits associated with nicotine withdrawal in rats. Eur J Pharmacol 554 (2007) 164-174
93. Bespalov A.Y., Dravolina O.A., Sukhanov I., Zakharova E., Blokhina E., Zvartau E., et al. Metabotropic glutamate receptor (mGluR5) antagonist MPEP attenuated cue- and schedule-induced reinstatement of nicotine self-administration behavior in rats. Neuropharmacology 49 (2005) 167-178
94. Paterson N.E., and Markou A. The metabotropic glutamate receptor 5 antagonist MPEP decreased break points for nicotine, cocaine and food in rats. Psychopharmacology 179 (2005) 255-261
95. Tessari M., Pilla M., Andreoli M., Hutcheson D.M., and Heidbreder C.A. Antagonism at metabotropic glutamate 5 receptors inhibits nicotine- and cocaine-taking behaviours and prevents nicotine-triggered relapse to nicotine-seeking. Eur J Pharmacol 499 (2004) 121-133
96. Paterson N.E., Semenova S., Gasparini F., and Markou A. The mGluR5 antagonist MPEP decreased nicotine self-administration in rats and mice. Psychopharmacology 167 (2003) 257-264
97. Papp M., Gruca P., and Willner P. Selective blockade of drug-induced place preference conditioning by ACPC, a functional NDMA-receptor antagonist. Neuropsychopharmacology 27 (2002) 727-743
98. Blokhina E.A., Kashkin V.A., Zvartau E.E., Danysz W., and Bespalov A.Y. Effects of nicotinic and NMDA receptor channel blockers on intravenous cocaine and nicotine self-administration in mice. Eur Neuropsychopharmacol 15 (2005) 219-225
99. Glick S.D., Maisonneuve I.M., Dickinson H.A., and Kitchen B.A. Comparative effects of dextromethorphan and dextrorphan on morphine, methamphetamine, and nicotine self-administration in rats. Eur J Pharmacol 422 (2001) 87-90
100. McGeehan A.J., and Olive M.F. The mGluR5 antagonist MPEP reduces the conditioned rewarding effects of cocaine but not other drugs of abuse. Synapse 47 (2003) 240-242
101. Brakeman P.R., Lanahan A.A., O'Brien R., Roche K., Barnes C.A., Huganir R.L., et al. Homer: a protein that selectively binds metabotropic glutamate receptors. Nature 386 (1997) 284-288
102. Foa L., Jensen K., Rajan I., Bronson K., Gasperini R., Worley P.F., et al. Homer expression in the Xenopus tadpole nervous system. J Comp Neurol 487 (2005) 42-53
103. Kato A., Ozawa F., Saitoh Y., Fukazawa Y., Sugiyama H., and Inokuchi K. Novel members of the Vesl/Homer family of PDZ proteins that bind metabotropic glutamate receptors. J Biol Chem 273 (1998) 23969-23975
104. Xiao B., Tu J.C., Petralia R.S., Yuan J.P., Doan A., Breder C.D., et al. Homer regulates the association of group 1 metabotropic glutamate receptors with multivalent complexes of homer-related, synaptic proteins. Neuron 21 (1998) 707-716
105. Shiraishi Y., Mizutani A., Yuasa S., Mikoshiba K., and Furuichi T. Differential expression of Homer family proteins in the developing mouse brain. J Comp Neurol 473 (2004) 582-599
106. Soloviev M.M., Ciruela F., Chan W.Y., and McIlhinney R.A. Mouse brain and muscle tissues constitutively express high levels of Homer proteins. Eur J Biochem 267 (2000) 634-639
107. Berke J.D., Paletzki R.F., Aronson G.J., Hyman S.E., and Gerfen C.R. A complex program of striatal gene expression induced by dopaminergic stimulation. J Neurosci 18 (1998) 5301-5310
108. Saito H., Kimura M., Inanobe A., Ohe T., and Kurachi Y. An N-terminal sequence specific for a novel Homer1 isoform controls trafficking of group I metabotropic glutamate receptor in mammalian cells. Biochem Biophys Res Commun 296 (2002) 523-529
109. Bottai D., Guzowski J.F., Schwarz M.K., Kang S.H., Xiao B., Lanahan A., et al. Synaptic activity-induced conversion of intronic to exonic sequence in Homer 1 immediate early gene expression. J Neurosci 22 (2002) 167-175
110. Klugmann M., Symes C.W., Leichtlein C.B., Klaussner B.K., Dunning J., Fong D., et al. AAV-mediated hippocampal expression of short and long Homer 1 proteins differentially affect cognition and seizure activity in adult rats. Mol Cell Neurosci. 28 (2005) 347-360
111. Girault J.A., Valjent E., Caboche J., and Herve D. ERK2: a logical AND gate critical for drug-induced plasticity?. Curr Opin Pharmacol 7 (2007) 77-85
112. Hope B.T. Cocaine and the AP-1 transcription factor complex. Ann N Y Acad Sci 844 (1998) 1-6
113. Lu L., Koya E., Zhai H., Hope B.T., and Shaham Y. Role of ERK in cocaine addiction. Trends Neurosci 29 (2006) 695-703
114. McClung C.A. The molecular mechanisms of morphine addiction. Rev Neurosci 17 (2006) 393-402
115. Nestler E.J. Molecular mechanisms of drug addiction. Neuropharmacology 47 Suppl 1 (2004) 24-32
116. Nestler E.J. Is there a common molecular pathway for addiction?. Nat Neurosci 8 (2005) 1445-1449
117. Pandey S.C. The gene transcription factor cyclic AMP-responsive element binding protein: role in positive and negative affective states of alcohol addiction. Pharmacol Ther 104 (2004) 47-58
118. Beneken J., Tu J.C., Xiao B., Nuriya M., Yuan J.P., Worley P.F., et al. Structure of the Homer EVH1 domain-peptide complex reveals a new twist in polyproline recognition. Neuron 26 (2000) 143-154
119. Gertler F.B., Niebuhr K., Reinhard M., Wehland J., and Soriano P. Mena, a relative of VASP and Drosophila Enabled, is implicated in the control of microfilament dynamics. Cell 87 (1996) 227-239
120. Reinhard M., Jarchau T., and Walter U. Actin-based motility: stop and go with Ena/VASP proteins. Trends Biochem Sci 26 (2001) 243-249
121. Kim E., and Sheng M. PDZ domain proteins of synapses. Nat Rev Neurosci 5 (2004) 771-781
122. Carpenter-Hyland E.P., and Chandler L.J. Adaptive plasticity of NMDA receptors and dendritic spines: implications for enhanced vulnerability of the adolescent brain to alcohol addiction. Pharmacol Biochem Behav 86 (2007) 200-208
123. Chiamulera C., Epping-Jordan M.P., Zocchi A., Marcon C., Cottiny C., Tacconi S., et al. Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice. Nat Neurosci 4 (2001) 873-874
124. Izzo E., Martin-Fardon R., Koob G.F., Weiss F., and Sanna P.P. Neural plasticity and addiction: PI3-kinase and cocaine behavioral sensitization. Nat Neurosci 5 (2002) 1263-1264
125. Hoffman P.L. NMDA receptors in alcoholism. Int Rev Neurobiol 56 (2003) 35-82
126. Krystal J.H., Petrakis I.L., Krupitsky E., Schutz C., Trevisan L., and D'Souza D.C. NMDA receptor antagonism and the ethanol intoxication signal: from alcoholism risk to pharmacotherapy. Ann N Y Acad Sci 1003 (2003) 176-184
127. Lee B., Platt D.M., Rowlett J.K., Adewale A.S., and Spealman R.D. Attenuation of behavioral effects of cocaine by the Metabotropic Glutamate Receptor 5 Antagonist 2-Methyl-6-(phenylethynyl)-pyridine in squirrel monkeys: comparison with dizocilpine. J Pharmacol Exp Ther 312 (2005) 1232-1240
128. Toda S., Shen H.W., Peters J., Cagle S., and Kalivas P.W. Cocaine increases actin cycling: effects in the reinstatement model of drug seeking. J Neurosci 26 (2006) 1579-1587
129. Zhang X., Mi J., Wetsel W.C., Davidson C., Xiong X., Chen Q., et al. PI3 kinase is involved in cocaine behavioral sensitization and its reversal with brain area specificity. Biochem Biophys Res Commun 340 (2006) 1144-1150
130. Ango F., Robbe D., Tu J.C., Xiao B., Worley P.F., Pin J.P., et al. Homer-dependent cell surface expression of metabotropic glutamate receptor type 5 in neurons. Mol Cell Neurosci 20 (2002) 323-329
131. Shiraishi Y., Mizutani A., Mikoshiba K., and Furuichi T. Coincidence in dendritic clustering and synaptic targeting of homer proteins and NMDA receptor complex proteins NR2B and PSD95 during development of cultured hippocampal neurons. Mol Cell Neurosci. 22 (2003) 188-201
132. Tu J.C., Xiao B., Yuan J.P., Lanahan A.A., Leoffert K., Li M., et al. Homer binds a novel proline-rich motif and links group 1 metabotropic glutamate receptors with IP3 receptors. Neuron 21 (1998) 717-726
133. Roche K.W., Tu J.C., Petralia R.S., Xiao B., Wenthold R.J., and Worley P.F. Homer 1b regulates the trafficking of group I metabotropic glutamate receptors. J Biol Chem 274 (1999) 25953-25957
134. Ango F., Pin J.P., Tu J.C., Xiao B., Worley P.F., Bockaert J., et al. Dendritic and axonal targeting of type 5 metabotropic glutamate receptor is regulated by homer1 proteins and neuronal excitation. J Neurosci 20 (2000) 8710-8716
135. Kammermeier P.J., Xiao B., Tu J.C., Worley P.F., and Ikeda S.R. Homer proteins regulate coupling of group I metabotropic glutamate receptors to N-type calcium and M-type potassium channels. J Neurosci 20 (2000) 7238-7245
136. Ango F., Prezeau L., Muller T., Tu J.C., Xiao B., Worley P.F., et al. Agonist-independent activation of metabotropic glutamate receptors by the intracellular protein Homer. Nature 411 (2001) 962-965
137. Naisbitt S., Kim E., Tu J.C., Xiao B., Sala C., Valtschanoff J., et al. Shank, a novel family of postsynaptic density proteins that binds to the NMDA receptor/PSD-95/GKAP complex and cortactin. Neuron 23 (1999) 569-582
138. Tu J.C., Xiao B., Naisbitt S., Yuan J.P., Petralia R.S., Brakeman P., et al. Coupling of mGluR/Homer and PSD-95 complexes by the Shank family of postsynaptic density proteins. Neuron 23 (1999) 583-592
139. 2+ homeostasis at dendritic spines in hippocampal neurons. J Neurosci 25 (2005) 4587-4592
140. Hwang J.I., Kim H.S., Lee J.R., Kim E., Ryu S.H., and Suh P.G. The interaction of phospholipase C-beta3 with Shank2 regulates mGluR-mediated calcium signal. J Biol Chem 280 (2005) 12467-12473
141. Nakamura M., Sato K., Fukaya M., Araishi K., Aiba A., Kano M., et al. Signaling complex formation of phospholipase Cbeta4 with metabotropic glutamate receptor type 1alpha and 1,4,5-trisphosphate receptor at the perisynapse and endoplasmic reticulum in the mouse brain. Eur J Neurosci 20 (2004) 2929-2944
142. Rong R., Ahn J.Y., Huang H., Nagata E., Kalman D., Kapp J.A., et al. PI3 kinase enhancer-Homer complex couples mGluRI to PI3 kinase, preventing neuronal apoptosis. Nat Neurosci 6 (2003) 1153-1161
143. Yuan J.P., Kiselyov K., Shin D.M., Chen J., Shcheynikov N., Kang S.H., et al. Homer binds TRPC family channels and is required for gating of TRPC1 by IP3 receptors. Cell 114 (2003) 777-789
144. Hayashi M.K., Ames H.M., and Hayashi Y. Tetrameric hub structure of postsynaptic scaffolding protein homer. J Neurosci 26 (2006) 8492-8501
145. Shin D.M., Dehoff M., Luo X., Kang S.H., Tu J., Nayak S.K., et al. Homer 2 tunes G protein-coupled receptors stimulus intensity by regulating RGS proteins and PLCbeta GAP activities. J Cell Biol 162 (2003) 293-303
146. Sun J., Tadokoro S., Imanaka T., Murakami S.D., Nakamura M., Kashiwada K., et al. Isolation of PSD-Zip45, a novel Homer/vesl family protein containing leucine zipper motifs, from rat brain. FEBS Lett 437 (1998) 304-308
147. Sala C., Piech V., Wilson N.R., Passafaro M., Liu G., and Sheng M. Regulation of dendritic spine morphology and synaptic function by Shank and Homer. Neuron 31 (2001) 115-130
148. de Bartolomeis A., and Iasevoli F. The Homer family and the signal transduction system at glutamatergic postsynaptic density: potential role in behavior and pharmacotherapy. Psychopharmacol Bull 37 (2003) 51-83
149. Shiraishi Y., Mizutani A., Bito H., Fujisawa K., Narumiya S., Mikoshiba K., et al. Cupidin, an isoform of Homer/Vesl, interacts with the actin cytoskeleton and activated rho family small GTPases and is expressed in developing mouse cerebellar granule cells. J Neurosci 19 (1999) 8389-8400
150. Fagni L., Worley P.F., and Ango F. Homer as both a scaffold and transduction molecule. Sci STKE (2002) RE8
151. Usui S., Konno D., Hori K., Maruoka H., Okabe S., Fujikado T., et al. Synaptic targeting of PSD-Zip45 (Homer 1c) and its involvement in the synaptic accumulation of F-actin. J Biol Chem 278 (2003) 10619-10628
152. Xiao B., Tu J.C., and Worley P.F. Homer: a link between neural activity and glutamate receptor function. Curr Opin Neurobiol 10 (2000) 370-374
153. Ajima R., Kajiya K., Inoue T., Tani M., Shiraishi-Yamaguchi Y., Maeda M., et al. HOMER2 binds MYO18B and enhances its activity to suppress anchorage independent growth. Biochem Biophys Res Commun 356 (2007) 851-856
154. Szumlinski K.K., Kalivas P.W., and Worley P.F. Homer proteins: implications for neuropsychiatric disorders. Curr Opin Neurobiol 16 (2006) 251-257
155. Kuriu T., Inoue A., Bito H., Sobue K., and Okabe S. Differential control of postsynaptic density scaffolds via actin-dependent and -independent mechanisms. J Neurosci 26 (2006) 7693-7706
156. Duncan R.S., Hwang S.Y., and Koulen P. Effects of Vesl/Homer proteins on intracellular signaling. Exp Biol Med 230 (2005) 527-535
157. Inoue Y., Honkura N., Kato A., Ogawa S., Udo H., Inokuchi K., et al. Activity-inducible protein Homer1a/Vesl-1S promotes redistribution of postsynaptic protein Homer1c/Vesl-1L in cultured rat hippocampal neurons. Neurosci Lett 354 (2004) 143-147
158. Kato A., Ozawa F., Saitoh Y., Hirai K., and Inokuchi K. vesl, a gene encoding VASP/Ena family related protein, is upregulated during seizure, long-term potentiation and synaptogenesis. FEBS Lett 412 (1997) 183-189
159. Shiraishi Y., Mizutani A., Mikoshiba K., and Furuichi T. Coincidence in dendritic clustering and synaptic targeting of homer proteins and NMDA receptor complex proteins NR2B and PSD95 during development of cultured hippocampal neurons. Mol Cell Neurosci 22 (2003) 188-201
160. McFarland K., and Kalivas P.W. The circuitry mediating cocaine-induced reinstatement of drug-seeking behavior. J Neurosci 21 (2001) 8655-8663
161. Koob G.F., and Le Moal M. Plasticity of reward neurocircuitry and the 'dark side' of drug addiction. Nat Neurosci 8 (2005) 1442-1444
162. Koob G.F. Alcoholism: allostasis and beyond. Alcohol Clin Exp Res 27 (2003) 232-243
163. Everitt B.J., and Robbins T.W. Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci 8 (2005) 1481-1489
164. Cardinal R.N., Parkinson J.A., Hall J., and Everitt B.J. Emotion and motivation: the role of the amygdala, ventral striatum, and prefrontal cortex. Neurosci Biobehav Rev 26 (2002) 321-352
165. See R.E. Neural substrates of cocaine-cue associations that trigger relapse. Eur J Pharmacol 526 (2005) 140-146
166. Ary A.W., Aguilar V.R., Szumlinski K.K., and Kippin T.E. Prenatal stress alters limbo-corticostriatal Homer protein expression. Synapse 61 (2007) 938-941
167. Kaja S., Yang S.H., Wei J., Fujitani K., Liu R., Brun-Zinkernagel A.M., et al. Estrogen protects the inner retina from apoptosis and ischemia-induced loss of Vesl-1L/Homer 1c immunoreactive synaptic connections. Invest Ophthalmol Vis Sci 44 (2003) 3155-3162
168. Fujiyama K., Kajii Y., Hiraoka S., and Nishikawa T. Differential regulation by stimulants of neocortical expression of mrt1, arc, and homer1a mRNA in the rats treated with repeated methamphetamine. Synapse 49 (2003) 143-149
169. Ghasemzadeh M.B., Acker C.J., Permenter L.K., Lake R., and Kalivas P.W. The regulation of Homer1 gene expression after acute and repeated cocaine administration in the mesocorticolimbic circuit. Soc Neurosci Abstr 831 (2006) 3
170. Nichols C.D., and Sanders-Bush E. A single dose of lysergic acid diethylamide influences gene expression patterns within the mammalian brain. Neuropsychopharmacology 26 (2002) 634-642
171. Nichols C.D., Garcia E.E., and Sanders-Bush E. Dynamic changes in prefrontal cortex gene expression following lysergic acid diethylamide administration. Mol Brain Res 111 (2003) 182-188
172. Kane J.K., Hwang Y., Konu O., Loughlin S.E., Leslie F.M., and Li M.D. Regulation of Homer and group I metabotropic glutamate receptors by nicotine. Eur J Neurosci 21 (2005) 1145-1154
173. Cochran S.M., Fujimura M., Morris B.J., and Pratt J.A. Acute and delayed effects of phencyclidine upon mRNA levels of markers of glutamatergic and GABAergic neurotransmitter function in the rat brain. Synapse 46 (2002) 206-214
174. Ammon S., Mayer P., Riechert U., Tischmeyer H., and Hollt V. Microarray analysis of genes expressed in the frontal cortex of rats chronically treated with morphine and after naloxone precipitated withdrawal. Mol Brain Res 112 (2003) 113-125
175. Zhang G.C., Mao L.M., Liu X.Y., Parelkar N.K., Arora A., Yang L., et al. In vivo regulation of Homer1a expression in the striatum by cocaine. Mol Pharmacol 71 (2007) 1148-1158
176. Ary A.W., Szumlinski K.K., and Ben-Shahar O. Brief versus extended access to cocaine differentially alters the expression of Group 1 mGluRs and Homer proteins in the prefrontal cortex of rats. Soc Neurosci Abstr 294 (2006) 2
177. Lominac K.D., Kapasova Z., Hannun R.A., Patterson C., Middaugh L.D., and Szumlinski K.K. Behavioral and neurochemical interactions between Group 1 mGluR antagonists and ethanol: potential insight into their anti-addictive properties. Drug Alcohol Depend 85 (2006) 142-156
178. Swanson C.J., Baker D.A., Carson D., Worley P.F., and Kalivas P.W. Repeated cocaine administration attenuates group I metabotropic glutamate receptor-mediated glutamate release and behavioral activation: a potential role for Homer. J Neurosci 21 (2001) 9043-9052
179. Szumlinski K.K. Homer1: A link between cortical glutamate dysfunction and cocaine addiction?. Soc Neurosci Abstr 699 (2006) 6
180. Sala C., Futai K., Yamamoto K., Worley P.F., Hayashi Y., and Sheng M. Inhibition of dendritic spine morphogenesis and synaptic transmission by activity-inducible protein Homer1a. J Neurosci 23 (2003) 6327-6337
181. Szumlinski K.K., Lominac K.D., Kleschen M.J., Oleson E.B., Dehoff M.H., Schwarz M.K., et al. Behavioral and neurochemical phenotyping of Homer1 mutant mice: possible relevance to schizophrenia. Genes Brain Behav 4 (2005) 273-288
182. Lominac K.D., Oleson E.B., Pava M., Klugmann M., Schwarz M.K., Seeburg P.H., et al. Distinct roles for different Homer1 isoforms in behaviors and associated prefrontal cortex function. J Neurosci 25 (2005) 11586-11594
183. Baker D.A., Shen H., and Kalivas P.W. Cystine/glutamate exchange serves as the source for extracellular glutamate: modifications by repeated cocaine administration. Amino Acids 23 (2002) 161-162
184. Melendez R.I., Vuthiganon J., and Kalivas P.W. Regulation of extracellular glutamate in the prefrontal cortex: focus on the cystine glutamate exchanger and group I metabotropic glutamate receptors. J Pharmacol Exp Ther 314 (2005) 139-147
185. Williams M, Reyes C, Szumlinski KK. Homer1 deletion does not alter mesolimbic glutamate receptor expression. Soc. Neurosci Abstr 881.7.
186. Brenman J.E., Christopherson K.S., Craven S.E., McGee A.W., and Bredt D.S. Cloning and characterization of postsynaptic density 93, a nitric oxide synthase interacting protein. J Neurosci 16 (1996) 7407-7415
187. Burette A., Zabel U., Weinberg R.J., Schmidt H.H., and Valtschanoff J.G. Synaptic localization of nitric oxide synthase and soluble guanylyl cyclase in the hippocampus. J Neurosci 22 (2002) 8961-8970
188. Christopherson K.S., Hillier B.J., Lim W.A., and Bredt D.S. PSD-95 assembles a ternary complex with the N-methyl-d-aspartic acid receptor and a bivalent neuronal NO synthase PDZ domain. J Biol Chem 274 (1999) 27467-27473
189. Bredt D.S., and Snyder S.H. Transient nitric oxide synthase neurons in embryonic cerebral cortical plate, sensory ganglia, and olfactory epithelium. Neuron 13 (1994) 301-313
190. Moncada S. The 1991 Ulf von Euler Lecture. The L-arginine: nitric oxide pathway. Acta Physiol Scand 145 (1992) 201-227
191. Bredt D.S., and Snyder S.H. Nitric oxide: a physiologic messenger molecule. Annu Rev Biochem 63 (1994) 175-195
192. Moncada S., Palmer R.M., and Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43 (1991) 109-142
193. Robinson T.E., and Kolb B. Structural plasticity associated with exposure to drugs of abuse. Neuropharmacology 47 Suppl 1 (2004) 33-46
194. Stanwood G.D., and Levitt P. Drug exposure early in life: functional repercussions of changing neuropharmacology during sensitive periods of brain development. Curr Opin Pharmacol 4 (2004) 65-71
195. Garner C.C., Nash J., and Huganir R.L. PDZ domains in synapse assembly and signalling. Trends Cell Biol 10 (2000) 274-280
196. Kennedy M.B. Signal-processing machines at the postsynaptic density. Science 290 (2000) 750-754
197. Okabe S. Molecular anatomy of the postsynaptic density. Mol Cell Neurosci 34 (2007) 503-518
198. Scannevin R.H., and Huganir R.L. Postsynaptic organization and regulation of excitatory synapses. Nat Rev Neurosci 1 (2000) 133-141
199. Fagni L., Ango F., Perroy J., and Bockaert J. Identification and functional roles of metabotropic glutamate receptor-interacting proteins. Semin Cell Dev Biol 15 (2004) 289-298
200. Ehlers M.D. Molecular morphogens for dendritic spines. Trends Neurosci 25 (2002) 64-67
201. Engert F., and Bonhoeffer T. Dendritic spine changes associated with hippocampal long-term synaptic plasticity. Nature 399 (1999) 66-70
202. Korkotian E., and Segal M. Bidirectional regulation of dendritic spine dimensions by glutamate receptors. NeuroReport 10 (1999) 2875-2877
203. Kaech S., Brinkhaus H., and Matus A. Volatile anesthetics block actin-based motility in dendritic spines. Proc Natl Acad Sci USA 96 (1999) 10433-10437
204. Maletic-Savatic M., Malinow R., and Svoboda K. Rapid dendritic morphogenesis in CA1 hippocampal dendrites induced by synaptic activity. Science 283 (1999) 1923-1927
205. Toni N., Buchs P.A., Nikonenko I., Bron C.R., and Muller D. LTP promotes formation of multiple spine synapses between a single axon terminal and a dendrite. Nature 402 (1999) 421-425
206. Kaech S., Parmar H., Roelandse M., Bornmann C., and Matus A. Cytoskeletal microdifferentiation: a mechanism for organizing morphological plasticity in dendrites. Proc Natl Acad Sci USA 98 (2001) 7086-7092
207. Robinson T.E., and Kolb B. Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine. J Neurosci 17 (1997) 8491-8497
208. Robinson T.E., and Kolb B. Alterations in the morphology of dendrites and dendritic spines in the nucleus accumbens and prefrontal cortex following repeated treatment with amphetamine or cocaine. Eur J Neurosci 11 (1999) 1598-1604
209. Ferrario C.R., Gorny G., Crombag H.S., Li Y., Kolb B., and Robinson T.E. Neural and behavioral plasticity associated with the transition from controlled to escalated cocaine use. Biol Psychiatry 58 (2005) 751-759
210. Heijtz R.D., Kolb B., and Forssberg H. Can a therapeutic dose of amphetamine during pre-adolescence modify the pattern of synaptic organization in the brain?. Eur J Neurosci 18 (2003) 3394-3399
211. Kolb B., Gorny G., Li Y., Samaha A.N., and Robinson T.E. Amphetamine or cocaine limits the ability of later experience to promote structural plasticity in the neocortex and nucleus accumbens. Proc Natl Acad Sci USA 100 (2003) 10523-10528
212. Li Y., Kolb B., and Robinson T.E. The location of persistent amphetamine-induced changes in the density of dendritic spines on medium spiny neurons in the nucleus accumbens and caudate-putamen. Neuropsychopharmacology 238 (2003) 1082-1085
213. Crombag H.S., Gorny G., Li Y., Kolb B., and Robinson T.E. Opposite effects of amphetamine self-administration experience on dendritic spines in the medial and orbital prefrontal cortex. Cereb Cortex 15 (2005) 341-348
214. Robinson T.E., Gorny G., Mitton E., and Kolb B. Cocaine self-administration alters the morphology of dendrites and dendritic spines in the nucleus accumbens and neocortex. Synapse 39 (2001) 257-266
215. Li Y., Acerbo M.J., and Robinson T.E. The induction of behavioural sensitization is associated with cocaine-induced structural plasticity in the core (but not shell) of the nucleus accumbens. Eur J Neurosci 20 (2004) 1647-1654
216. Norrholm S.D., Bibb J.A., Nestler E.J., Ouimet C.C., Taylor J.R., and Greengard P. Cocaine-induced proliferation of dendritic spines in nucleus accumbens is dependent on the activity of cyclin-dependent kinase-5. Neuroscience 116 (2003) 19-22
217. Brown R.W., and Kolb B. Nicotine sensitization increases dendritic length and spine density in the nucleus accumbens and cingulate cortex. Brain Res 899 (2001) 94-100
218. Gonzalez C.L., Gharbawie O.A., Whishaw I.Q., and Kolb B. Nicotine stimulates dendritic arborization in motor cortex and improves concurrent motor skill but impairs subsequent motor learning. Synapse 55 (2005) 183-191
219. Robinson T.E., and Kolb B. Morphine alters the structure of neurons in the nucleus accumbens and neocortex of rats. Synapse 33 (1999) 160-162
220. Robinson T.E., Gorny G., Savage V.R., and Kolb B. Widespread but regionally specific effects of experimenter- versus self-administered morphine on dendritic spines in the nucleus accumbens, hippocampus, and neocortex of adult rats. Synapse 46 (2002) 271-279
221. Lescaudron L., Jaffard R., and Verna A. Modifications in number and morphology of dendritic spines resulting from chronic ethanol consumption and withdrawal: a Golgi study in the mouse anterior and posterior hippocampus. Exp Neurol 106 (1989) 156-163
222. Tarelo-Acuna L., Olvera-Cortes E., and Gonzalez-Burgos I. Prenatal and postnatal exposure to ethanol induces changes in the shape of the dendritic spines from hippocampal CA1 pyramidal neurons of the rat. Neurosci Lett 286 (2000) 13-16
223. Carpenter-Hyland E.P., and Chandler L.J. Homeostatic plasticity during alcohol exposure promotes enlargement of dendritic spines. Eur J Neurosci 24 (2006) 3496-3506
224. Zhou F.C., Anthony B., Dunn K.W., Lindquist W.B., Xu Z.C., and Deng P. Chronic alcohol drinking alters neuronal dendritic spines in the brain reward center nucleus accumbens. Brain Res 1134 (2007) 148-161
225. Carpenter-Hyland E.P., Woodward J.J., and Chandler L.J. Chronic ethanol induces synaptic but not extrasynaptic targeting of NMDA receptors. J Neurosci 24 (2004) 7859-7868
226. Chandler L.J. Ethanol and brain plasticity: receptors and molecular networks of the postsynaptic density as targets of ethanol. Pharmacol Ther 99 (2003) 311-326
227. Okabe S., Urushido T., Konno D., Okado H., and Sobue K. Rapid redistribution of the postsynaptic density protein PSD-Zip45 (Homer 1c) and its differential regulation by NMDA receptors and calcium channels. J Neurosci 21 (2001) 9561-9571
228. Ebihara T., Kawabata I., Usui S., Sobue K., and Okabe S. Synchronized formation and remodeling of postsynaptic densities: long-term visualization of hippocampal neurons expressing postsynaptic density proteins tagged with green fluorescent protein. J Neurosci 23 (2003) 2170-2181
229. Foa L., Rajan I., Haas K., Wu G.Y., Brakeman P., Worley P., et al. The scaffold protein, Homer1b/c, regulates axon pathfinding in the central nervous system in vivo. Nat Neurosci 4 (2001) 499-506
230. Murmu M.S., Salomon S., Biala Y., Weinstock M., Braun K., and Bock J. Changes of spine density and dendritic complexity in the prefrontal cortex in offspring of mothers exposed to stress during pregnancy. Eur J Neurosci 24 (2006) 1477-1487
231. Rebec G.V., and Sun W. Neuronal substrates of relapse to cocaine-seeking behavior: role of prefrontal cortex. J Exp Anal Behav 84 (2005) 653-666
232. Carlezon Jr. W.A., and Nestler E.J. Elevated levels of GluR1 in the midbrain: a trigger for sensitization to drugs of abuse?. Trends Neurosci 25 (2002) 610-615
233. Kalivas P.W. Recent understanding in the mechanisms of addiction. Curr Psychiatry Rep 6 (2004) 347-351
234. Self D.W., and Choi K.H. Extinction-induced neuroplasticity attenuates stress-induced cocaine seeking: a state-dependent learning hypothesis. Stress 7 (2004) 145-155
235. Wang J.Q., Liu X., Zhang G., Parelkar N.K., Arora A., Haines M., et al. Phosphorylation of glutamate receptors: a potential mechanism for the regulation of receptor function and psychostimulant action. J Neurosci Res 84 (2006) 1621-1629
236. Koe B.K. Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain. J Pharmacol Exp Ther 199 (1976) 649-661
237. Ary AW, Szumlinski KK. Regionally selective regulation of Homer proteins by withdrawal from repeated cocaine. Soc Neurosci Abstr 271.27.
238. Ahmed S.H., and Koob G.F. Transition to drug addiction: a negative reinforcement model based on an allostatic decrease in reward function. Psychopharmacology 180 (2005) 473-490
239. Ben-Shahar O., Ahmed S.H., Koob G.F., and Ettenberg A. The transition from controlled to compulsive drug use is associated with a loss of sensitization. Brain Res 995 (2004) 46-54
240. Ben-Shahar O., Keeley P., Cook M., Brake W., Joyce M., Nyffeler M., et al. Changes in levels of D1, D2, or NMDA receptors during withdrawal from brief or extended daily access to IV cocaine. Brain Res 1131 (2007) 220-228
241. Ahmed S.H., and Cador M. Dissociation of psychomotor sensitization from compulsive cocaine consumption. Neuropsychopharmacology 31 (2006) 563-571
242. Ben-Shahar O., Moscarello J.M., Jacob B., Roarty M.P., and Ettenberg A. Prolonged daily exposure to i.v. cocaine results in tolerance to its stimulant effects. Pharmacol Biochem Behav 82 (2005) 411-416
243. Ben-Shahar O., Moscarello J.M., and Ettenberg A. One hour, but not six hours, of daily access to self-administered cocaine results in elevated levels of the dopamine transporter. Brain Res 1095 (2006) 148-153
244. Mantsch J.R., Yuferov V., Mathieu-Kia A.M., Ho A., and Kreek M.J. Effects of extended access to high versus low cocaine doses on self-administration, cocaine-induced reinstatement and brain mRNA levels in rats. Psychopharmacology 175 (2004) 26-36
245. Obara I, Ary AW, Szumlinski KK, Ben-Shahar O. Differential alterations in mesocorticolimbic Homer and glutamate receptor protein expression by one and six hours of daily access to self-administered cocaine. Soc Neurosci Abstr 271.26.
246. Ghasemzadeh M.B., Permenter L.K., Lake R., Worley P.F., and Kalivas P.W. Homer1 proteins and AMPA receptors modulate cocaine-induced behavioural plasticity. Eur J Neurosci 18 (2003) 1645-1651
247. Dietrich J.B., Arpin-Bott M.P., Kao D., Dirrig-Grosch S., Aunis D., and Zwiller J. Cocaine induces the expression of homer 1b/c, homer 3a/b, and hsp 27 proteins in rat cerebellum. Synapse 61 (2007) 587-594
248. Tappe A., and Kuner R. Regulation of motor performance and striatal function by synaptic scaffolding proteins of the Homer1 family. Proc Natl Acad Sci USA 103 (2006) 774-779
249. Dahl J.P., Kampman K.M., Oslin D.W., Weller A.E., Lohoff F.W., Ferraro T.N., et al. Association of a polymorphism in the Homer1 gene with cocaine dependence in an African American population. Psychiatr Genet 15 (2005) 277-283
250. Minami K., Gereau IV R.W., Minami M., Heinemann S.F., and Harris R.A. Effects of ethanol and anesthetics on type 1 and 5 metabotropic glutamate receptors expressed in Xenopus oocytes. Mol Pharmacol 53 (1998) 148-156
251. Lovinger D.M. Interactions between ethanol and agents that act on the NMDA-type glutamate receptor. Alcohol Clin Exp Res 20 Suppl (1996) 187A-191A
252. Woodward J.J. Ethanol and NMDA receptor signaling. Crit Rev Neurobiol 14 (2000) 69-89
253. Dahchour A., Quertemont E., and De Witte P. Acute ethanol increases taurine but neither glutamate nor GABA in the nucleus accumbens of male rats: a microdialysis study. Alcohol Alcohol 29 (1994) 485-487
254. Dahchour A., De Witte P., Bolo N., Nedelec J.F., Muzet M., Durbin P., et al. Central effects of acamprosate: part 1. Acamprosate blocks the glutamate increase in the nucleus accumbens microdialysate in ethanol withdrawn rats. Psychiatry Res 82 (1998) 107-114
255. Dahchour A., and De Witte P. Taurine blocks the glutamate increase in the nucleus accumbens microdialysate of ethanol-dependent rats. Pharmacol Biochem Behav 65 (2000) 345-350
256. Melendez R.I., Hicks M.P., Cagle S.S., and Kalivas P.W. Ethanol exposure decreases glutamate uptake in the nucleus accumbens. Alcohol Clin Exp Res 29 (2005) 326-333
257. Dahchour A., and De Witte P. Excitatory and inhibitory amino acid changes during repeated episodes of ethanol withdrawal: an in vivo microdialysis study. Eur J Pharmacol 459 (2003) 171-178
258. Dahchour A., and De Witte P. Effects of acamprosate on excitatory amino acids during multiple ethanol withdrawal periods. Alcohol Clin Exp Res 27 (2003) 465-470
259. Szumlinski K.K., Diab M.E., Friedman R., Henze L.M., Lominac K.D., and Bowers M.S. Accumbens neurochemical adaptations produced by binge-like alcohol consumption. Psychopharmacology 190 (2007) 415-431
260. Hendricson A.W., Maldve R.E., Salinas A.G., Theile J.W., Zhang T.A., Diaz L.M., et al. Aberrant synaptic activation of NMDA receptors underlies ethanol withdrawal hyperexcitability. J Pharmacol Exp Ther 321 (2007) 60-72
261. Smothers C.T., Mrotek J.J., and Lovinger D.M. Chronic ethanol exposure leads to a selective enhancement of N-methyl-d-aspartate receptor function in cultured hippocampal neurons. J Pharmacol Exp Ther 283 (1997) 1214-1222
262. Chen F., Jarrott B., and Lawrence A.J. Up-regulation of cortical AMPA receptor binding in the fawn-hooded rat following ethanol withdrawal. Eur J Pharmacol 384 (1999) 139-146
263. Szumlinski K.K. Up and away! Facilitation of alcohol-induced neural plasticity by Homer over-expression. Alcohol Clin Exp Ther 30 Suppl (2006) 60A
264. Szumlinski K.K., Friedman J., Rahn A., Cozzoli D., and Ary A.W. Excessive alcohol consumption sensitizes glutamate transmission: Link to Homer proteins and kinase activation. Neuropsychopharmacology 31 (2006) S140
265. Olive M.F., McGeehan A.J., Kinder J.R., McMahon T., Hodge C.W., Janak P.H., et al. The mGluR5 antagonist 6-methyl-2-(phenylethynyl)pyridine decreases ethanol consumption via a protein kinase C epsilon-dependent mechanism. Mol Pharmacol 67 (2005) 349-355
266. Gutala R., Wang J., Kadapakkam S., Hwang Y., Ticku M., and Li M.D. Microarray analysis of ethanol-treated cortical neurons reveals disruption of genes related to the ubiquitin-proteasome pathway and protein synthesis. Alcohol Clin Exp Res 28 (2004) 1779-1788
267. Sokolov B.P., Jiang L., Trivedi N.S., and Aston C. Transcription profiling reveals mitochondrial, ubiquitin and signaling systems abnormalities in postmortem brains from subjects with a history of alcohol abuse or dependence. J Neurosci Res 72 (2003) 756-767
268. Urizar N.L., Yang Z., Edenberg H.J., and Davis R.L. Drosophila homer is required in a small set of neurons including the ellipsoid body for normal ethanol sensitivity and tolerance. J Neurosci 27 (2007) 4541-4551
269. Diagana T.T., Thomas U., Prokopenko S.N., Xiao B., Worley P.F., and Thomas J.B. Mutation of Drosophila homer disrupts control of locomotor activity and behavioral plasticity. J Neurosci 22 (2002) 428-436
270. Melega W.P., Williams A.E., Schmitz D.A., DiStefano E.W., and Cho A.K. Pharmacokinetic and pharmacodynamic analysis of the actions of d-amphetamine and d-methamphetamine on the dopamine terminal. J Pharmacol Exp Ther 274 (1995) 90-96
271. Sulzer D., Sonders M.S., Poulsen N.W., and Galli A. Mechanisms of neurotransmitter release by amphetamines: A review. Prog. Neurobiol 75 (2005) 406-433
272. Fleckenstein A.E., Metzger R.R., Wilkins D.G., Gibb J.W., and Hanson G.R. Rapid and reversible effects of methamphetamine on dopamine transporters. J Pharmacol Ex Ther 282 (1997) 834-838
273. Kita T., Wagner G.C., and Nakashima T. Current research on methamphetamine-induced neurotoxicity: animal models of monoamine disruption. J Pharmacol Sci 92 (2003) 178-195
274. Sato M., Numachi Y., and Hamamura T. Relapse of paranoid psychotic state in methamphetamine model of schizophrenia. Schizophr Bull 18 (1992) 115-122
275. Imam S.Z., el-Yazal J., Newport G.D., Itzhak Y., Cadet J.L., Slikker Jr. W., et al. Methamphetamine-induced dopaminergic neurotoxicity: role of peroxynitrite and neuroprotective role of antioxidants and peroxynitrite decomposition catalysts. Ann N Y Acad Sci 939 (2001) 366-380
276. Sonsalla P.K. The role of N-methyl-d-aspartate receptors in dopaminergic neuropathology produced by the amphetamines. Drug Alcohol Depend 37 (1995) 101-105
277. Robinson T.E., Castaneda E., and Whishaw I.Q. Compensatory changes in striatal dopamine neurons following recovery from injury induced by 6-OHDA or methamphetamine: a review of evidence from microdialysis studies. Can J Psychol 44 (1990) 253-275
278. Seiden L.S., Commins D.L., Vosmer G., Axt K., and Marek G. Neurotoxicity in dopamine and 5-hydroxytryptamine terminal fields: a regional analysis in nigrostriatal and mesolimbic projections. Ann N Y Acad Sci 537 (1988) 161-172
279. Shoblock J.R., Sullivan E.B., Maisonneuve I.M., and Glick S.D. Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in rats. Psychopharmacology 165 (2003) 359-369
280. Zhang Y., Loonam T.M., Noailles P.A., and Angulo J.A. Comparison of cocaine- and methamphetamine-evoked dopamine and glutamate overflow in somatodendritic and terminal field regions of the rat brain during acute, chronic, and early withdrawal conditions. Ann N Y Acad Sci 937 (2001) 93-120
281. Kim J.S., Kornhuber H.H., Brand U., and Menge H.G. Effects of chronic amphetamine treatment on the glutamate concentration in cerebrospinal fluid and brain: implications for a theory of schizophrenia. Neurosci Lett 24 (1981) 93-96
282. Nash J.F., and Yamamoto B.K. Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine. Brain Res 581 (1992) 237-243
283. Stephans S.E., and Yamamoto B.K. Methamphetamine-induced neurotoxicity: roles for glutamate and dopamine efflux. Synapse 17 (1994) 203-209
284. Abekawa T., Ohmori T., and Koyama T. Effects of repeated administration of a high dose of methamphetamine on dopamine and glutamate release in rat striatum and nucleus accumbens. Brain Res 643 (1994) 276-281
285. Stephans S.E., and Yamamoto B.Y. Effect of repeated methamphetamine administrations on dopamine and glutamate efflux in rat prefrontal cortex. Brain Res 700 (1995) 99-106
286. Lu W., Chen H., Xue C.J., and Wolf M.E. Repeated amphetamine administration alters the expression of mRNA for AMPA receptor subunits in rat nucleus accumbens and prefrontal cortex. Synapse 26 (1997) 269-280
287. Lu W., and Wolf M.E. Repeated amphetamine administration alters AMPA receptor subunit expression in rat nucleus accumbens and medial prefrontal cortex. Synapse 32 (1999) 119-131
288. Lu W., Monteggia L.M., and Wolf M.E. Withdrawal from repeated amphetamine administration reduces NMDAR1 expression in the rat substantia nigra, nucleus accumbens and medial prefrontal cortex. Eur J Neurosci 11 (1999) 3167-3177
289. Eisch A.J., O'Dell S.J., and Marshall J.F. Striatal and cortical NMDA receptors are altered by a neurotoxic regimen of methamphetamine. Synapse 22 (1996) 217-225
290. Kashiwabara K., Sato M., and Otsuki S. Reduction of 3H-kainic acid binding in rat cerebral cortex by chronic methamphetamine administration. Biol Psychiat 19 (1984) 1173-1181
291. Ghasemzadeh M.B., Nelson L.C., Lu X.Y., and Kalivas P.W. Neuroadaptations in ionotropic and metabotropic glutamate receptor mRNA produced by cocaine treatment. J Neurochem 72 (1999) 157-165
292. Boudreau A.C., and Wolf M.E. Behavioral sensitization to cocaine is associated with increased AMPA receptor surface expression in the nucleus accumbens. J Neurosci 25 (2005) 9144-9151
293. Churchill L., Swanson C.J., Urbina M., and Kalivas P.W. Repeated cocaine alters glutamate receptor subunit levels in the nucleus accumbens and ventral tegmental area of rats that develop behavioral sensitization. J Neurochem 72 (1999) 2397-2403
294. Lominac K.D., and Szumlinski K.K. Up-regulation of Homer and glutamate receptor protein expression in the nucleus accumbens by psychomimetic and anti-psychotic agents. Soc Neurosci Abstr 589 (2006) 1
295. Koob G.F. The neurobiology of addiction: a neuroadaptational view relevant for diagnosis. Addiction 101 Suppl 1 (2006) 23-30
296. Bossert J.M., Ghitza U.E., Lu L., Epstein D.H., and Shaham Y. Neurobiology of relapse to heroin and cocaine seeking: an update and clinical implications. Eur J Pharmacol 526 (2005) 36-50
297. Kreek M.J., Nielsen D.A., Butelman E.R., and LaForge K.S. Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction. Nat Neurosci 8 (2005) 1450-1457
298. Goeders N.E. The impact of stress on addiction. Eur Neuropsychopharmacol 13 (2003) 435-441
299. Lu L., Shepard J.D., Hall F.S., and Shaham Y. Effect of environmental stressors on opiate and psychostimulant reinforcement, reinstatement and discrimination in rats: a review. Neurosci Biobehav Rev 27 (2003) 457-491
300. Yang J., Li W., Liu X., Li Z., Li H., Yang G., et al. Enriched environment treatment counteracts enhanced addictive and depressive-like behavior induced by prenatal chronic stress. Brain Res 1125 (2006) 132-137
301. Ludman E.J., McBride C.M., Nelson J.C., Curry S.J., Grothaus L.C., Lando H.A., et al. Stress, depressive symptoms, and smoking cessation among pregnant women. Health Psychol 19 (2000) 21-27
302. Deminiere J.M., Piazza P.V., Guegan G., Abrous N., Maccari S., Le Moal M., et al. Increased locomotor response to novelty and propensity to intravenous amphetamine self-administration in adult offspring of stressed mothers. Brain Res 586 (1992) 135-139
303. Kippin TE, Szumlinski KK, Kapasova Z, Rezner B, See RE. Prenatal stress enhances the psychomotor stimulant, motivational, and neurochemical effects of cocaine. Neuropsychopharmacology; in press, doi:10.1038/sj.npp.1301447.
304. Brown S.M., Henning S., and Wellman C.L. Mild, short-term stress alters dendritic morphology in rat medial prefrontal cortex. Cereb Cortex 15 (2005) 1714-1722
305. Cook S.C., and Wellman C.L. Chronic stress alters dendritic morphology in rat medial prefrontal cortex. J Neurobiol 60 (2004) 236-248
306. Kolb B., Gorny G., Soderpalm A.H., and Robinson T.E. Environmental complexity has different effects on the structure of neurons in the prefrontal cortex versus the parietal cortex or nucleus accumbens. Synapse 48 (2003) 149-153
307. Venton B.J., Robinson T.E., and Kennedy R.T. Transient changes in nucleus accumbens amino acid concentrations correlate with individual responsivity to the predator fox odor 2,5-dihydro-2,4,5-trimethylthiazoline. J Neurochem 96 (2006) 236-246
308. Moghaddam B. Stress preferentially increases extraneuronal levels of excitatory amino acids in the prefrontal cortex: comparison to hippocampus and basal ganglia. J Neurochem 60 (1993) 1650-1657
309. Saulskaya N., and Marsden C.A. Extracellular glutamate in the nucleus accumbens during a conditioned emotional response in the rat. Brain Res 698 (1995) 114-120
310. Vazdarjanova A., McNaughton B.L., Barnes C.A., Worley P.F., and Guzowski J.F. Experience-dependent coincident expression of the effector immediate-early genes arc and Homer 1a in hippocampal and neocortical neuronal networks. J Neurosci 22 (2002) 10067-10071
311. Igaz L.M., Bekinschtein P., Izquierdo I., and Medina J.H. One-trial aversive learning induces late changes in hippocampal CaMKIIalpha, Homer 1a, Syntaxin 1a and ERK2 protein levels. Brain Res Mol Brain Res 132 (2004) 1-12
312. Koenig J.I., Elmer G.I., Shepard P.D., Lee P.R., Mayo C., Joy B., et al. Prenatal exposure to a repeated variable stress paradigm elicits behavioral and neuroendocrinological changes in the adult offspring: potential relevance to schizophrenia. Behav Brain Res 156 (2005) 251-261
313. Weinstock M. Alterations induced by gestational stress in brain morphology and behaviour of the offspring. Prog Neurobiol 65 (2001) 427-451
314. Henry C., Guegant G., Cador M., Arnauld E., Arsaut J., Le Moal M., et al. Prenatal stress in rats facilitates amphetamine-induced sensitization and induces long-lasting changes in dopamine receptors in the nucleus accumbens. Brain Res 685 (1995) 179-186
315. Jaubert P.J., Golub M.S., Lo Y.Y., Germann S.L., Dehoff M.H., Worley P.F., et al. Complex, multimodal behavioral profile of the Homer1 knockout mouse. Genes Brain Behav 6 (2007) 141-154
316. Alterman A.I., Erdlen D.L., Laporte D.L., and Erdlen F.R. Effects of illicit drug use in an inpatient psychiatric setting. Addict Behav 73 (1982) 231-242
317. Barbee J.G., Clark P.D., Crapanzano M.S., Heintz G.C., and Kehoe C.E. Alcohol and substance abuse among schizophrenic patients present to an emergency psychiatric service. J Nerv Mental Dis 177 (1989) 400-407
318. Drake R.E., Osher F.C., and Wallach M.A. Alcohol use and abuse in schizophrenia: a prospective community study. J Nerv Mental Dis 177 (1989) 408-414
319. Mueser K.T., Yarnold P.R., and Bellack A.S. Diagnostic and demographic correlates of substance abuse in schizophrenia and major affective disorder. Acta Psychiat Scand 85 (1992) 48-55
320. Mueser K.T., Bennett M., and Kushner M.G. Epidemiology of substance use disorders among persons with chronic mental illnesses. In: Lehman A.F., and Dixon L.B. (Eds). Double jeopardy: chronic mental illness and substance use disorders vol. 3 (1995), Harwood Academic Publishers, Longhorne, Pennsylvania 9-25
321. Schneier F.R., and Siris S.G. A review of psychoactive substance use and abuse in schizophrenia: patterns of drug choice. J Nerv Mental Dis 175 (1987) 641-652
322. Regier D.A., Farmer M.E., Rae D.S., Locke B.Z., Keith S.J., Judd L.L., et al. Comorbidity of mental disorders with alcohol and other drug abuse. J Am Med Assoc 264 (1990) 2511-2518
323. Dixon L. Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes. Schizophr Res 35 (1999) 93-100
324. Hays P., and Aidroos N. Alcoholism followed by schizophrenia. Acta Psychiat Scand 742 (1985) 187-189
325. Negrete J.C., and Knapp W.P. The effects of cannabis use on the clinical condition of schizophrenics. NIDA Res Monogr 67 (1986) 321-327
326. Swartz M.S., Swanson J.W., Hiday V.A., Borum R., Wagner H.R., and Burns B.J. Violence and severe mental illness: the effects of substance abuse and nonadherence to medication. Am J Psychiat 155 (1998) 226-231
327. Tracy J.I., Josiassen R.C., and Bellack A.S. Neuropsychology of dual diagnosis: understanding the combined effects of schizophrenia and substance use disorders. Clin Psychol Rev 15 (1995) 67-97
328. Cohen L.J., Test M.A., and Brown R.J. Suicide and schizophrenia: data from a prospective community treatment study. Am J Psychiat 147 (1990) 602-607
329. Landmark J., Cernovsky Z.Z., and Merskey H. Correlates of suicide attempts and ideation in schizophrenia. Brit J Psychiat 151 (1987) 18-20
330. Carpenter W.T.J., Heinrichs D.W., and Alphs L.D. Treatment of negative symptoms. Schizophr Bull 11 (1985) 440-452
331. Linszen D.H., Dingemans P.M., and Lenior M.E. Cannabis abuse and the course of recent-onset schizophrenic disorders. Arch Gen Psychiat 51 (1994) 273-279
332. Sokolski K.N., Cummings J.L., Abrams B.I., DeMet E.M., Katz L.S., and Costa J.F. Effects of substance abuse on hallucination rates and treatment responses in chronic psychiatric patients. J Clin Psychiat 55 (1994) 380-387
333. Haywood T.W., Kravitz H.M., Grossman L.S., Cavanaugh Jr. J.L., Davis J.M., and Lewis D.A. Predicting the "revolving door" phenomenon among patients with schizophrenic, schizoaffective, and affective disorders. Am J Psychiat 152 (1995) 856-861
334. Norton N., Williams H.J., Williams N.M., Spurlock G., Zammit S., Jones G., et al. Mutation screening of the Homer gene family and association analysis in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 120 (2003) 18-21
335. Fourgeaud L., Mato S., Bouchet D., Hemar A., Worley P.F., and Manzoni O.J. A single in vivo exposure to cocaine abolishes endocannabinoid-mediated long-term depression in the nucleus accumbens. J Neurosci 24 (2004) 6939-6945